Activation of the ERK/MAP Kinase Pathway in Cervical Intraepithelial Neoplasia Is Related to Grade of the Lesion but not to High-Risk Human Papillomavirus, Virus Clearance, or Prognosis in Cervical Cancer

This publication has 24 references indexed in Scilit:

• Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
  JNCI Monographs, 2003
• Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells
  Proceedings of the National Academy of Sciences, 2003
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
  European Journal Of Cancer, 2002
• Papillomaviruses and cancer: from basic studies to clinical application
  Nature Reviews Cancer, 2002
• Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation
  Journal of Biological Chemistry, 2002
• Induction of pRb Degradation by the Human Papillomavirus Type 16 E7 Protein Is Essential To Efficiently Overcome p16 ^INK4a -Imposed G ₁ Cell Cycle Arrest
  Journal of Virology, 2001
• Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer
  JNCI Journal of the National Cancer Institute, 2001
• Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein
  Oncogene, 1997
• The Human Papillomavirus Type 16 E5 Gene Cooperates with the E7 Gene to Stimulate Proliferation of Primary Cells and Increases Viral Gene Expression
  Virology, 1994